|
1.IntroductionDiffuse optical spectroscopy with near-infrared light can assess tumor angiogenesis based on tissue hemoglobin concentrations. The concentrations of oxygenated and deoxygenated hemoglobin can be calculated from the absorption coefficient at multiple wavelengths. As optical spectroscopy is not expensive and can be repeated without ionizing radiation, this technique is promising for assessment of the effects of neoadjuvant chemotherapy for breast cancer.1,2 In the measurement of the absorption coefficient of breast cancer by optical spectroscopy, the surrounding mammary glands and fat are inevitably included in the measurement. Furthermore, chest wall muscles may be included when the skin-to-chest wall distance is small. We have demonstrated that hemoglobin measurement in breast cancer by time-resolved spectroscopy (TRS) was influenced by the chest wall muscles.3 Tumor size and depth may also affect the measurement because the path length of light in the tumor and relative amount of light that reaches the tumor are different among tumors depending on their size and depth. Although changes in tissue oxygen saturation () may indicate the effectiveness of chemotherapy,4,5 there is no consensus on the level in breast cancer. The reduced scattering coefficient () is another optical parameter that provides information on tissue structure and composition.6 However, these indices may depend on the skin-to-chest wall distance. The purpose of this study was to evaluate the effects of tumor size and depth on hemoglobin measurement in breast cancer and to report and in breast tissue and in breast cancer in relation with the skin-to-chest wall distance. 2.Materials and Methods2.1.Near-Infrared Time-Resolved SpectroscopyOptical properties of normal breast tissue and cancer were measured using a single-channel near-infrared TRS system (TRS-20SH, Hamamatsu Photonics K.K., Hamamatsu, Japan). This system uses a time-correlated single-photon counting method for acquiring the temporal response profiles from the tissue against optical impulse inputs and enables quantitative analysis of light absorption and scattering in tissue by the photon diffusion theory.7 An ultrashort pulsed laser light source (PLP, Hamamatsu Photonics K.K.) emits light pulses at three different wavelengths (758, 795, and 833 nm) with an average power of , full width at half maximum (FWHM) of (ps), and repetition frequency of 5 MHz. The detector section of this system consisted of a photomultiplier tube (H7422P-50MOD, Hamamatsu Photonics K.K.) followed by constant fraction discriminators, time-to-amplitude converters, A/D converters, and histogram memories. The instrumental response function of the system was approximately FWHM. The three light sources emitted a pulse on a time series, and the three-wavelength optical pulses were guided into one optical fiber via a fiber coupler (NTT Advanced Technology Corp., Kawasaki, Japan). Each single optical fiber (GC200/250L, Fujikura Ltd., Tokyo, Japan) used for light irradiation had a numerical aperture (NA) of 0.25 and a core diameter of . The optical bundle fiber (SCHOTT MORITEX Corp., Asaka, Japan) used to collect the light had an NA of 0.26 and a bundle diameter of 3 mm. The nonlinear least-squares method was used to fit the solution of the time-domain photon diffusion equation with a semi-infinite homogeneous model to the observed temporal profiles. The zero boundary condition of the reflectance mode was employed. The time resolution of the temporal profile was 10 ps, and the data acquisition time was 3 s. The distance from the light source to the detector was 3 cm. The absorption coefficient and reduced scattering coefficient were obtained at each wavelength. The data over the time range from to 5440 ps were selected for fitting. The reduced chi-square value was used to evaluate fitting accuracy. Our fitting process was successfully implemented if this value was within the range of 0.8 to 1.2.8 The concentrations of oxygenated and deoxygenated hemoglobin were calculated from the absorption coefficient at each wavelength by the least-squares method after subtracting water and lipid absorption in breast tissue. We assumed that water content was 18.7% and lipid content was 66.1%.9 The concentration of tHb was the sum of the concentrations of oxygenated hemoglobin and deoxygenated hemoglobin. 2.2.UltrasonographyAn ultrasonography (US) system (EUB-7500, Hitachi Medical Corporation, Tokyo, Japan) with a linear probe (EUP-L65, Hitachi Medical Corporation) was used. The probe had a frequency range of 6 to 14 MHz. A spectroscopic probe was attached to the US probe.3 2.3.Patient CharacteristicsWe examined 86 patients with breast lesions between June 2013 and April 2016. We excluded 32 patients who had undergone chemotherapy or hormonal therapy. Three patients in whom the final diagnosis was not cancer were excluded. We excluded two patients just after biopsy and two patients just after subcutaneous injection of a radiopharmaceutical around the tumor for sentinel lymph node biopsy. We also excluded two patients whose tumors were undetectable on US and one patient in whom ultrasound images were not recorded. Finally, 44 patients were included in this study. All patients were female and their median age was 52.3 years, with a range of 33 to 78 years. Twenty patients were premenopausal and 24 patients were postmenopausal. The patients underwent TRS and US scan at least 12 days after core needle biopsy. Six patients had multiple lesions, and a total of 53 lesions were evaluated. Forty tumors were found to be invasive ductal cancer, 12 tumors were ductal carcinoma in situ, and one tumor was invasive lobular carcinoma. The mean maximum transverse diameter of the tumors was 19.5 mm, with a range of 7 to 61 mm. The study protocol was approved by the Ethical Review Committee of Hamamatsu University School of Medicine. All patients signed a written informed consent form. 2.4.TRS and US Scan ProtocolAfter the spectroscopic probe that was attached to the US probe was placed on the skin just above the tumor, the absorption coefficient and reduced scattering coefficient at three wavelengths were measured simultaneously. Tumor thickness, depth, and skin-to-chest wall distance were measured by US. The distance from the skin to the anterior surface of the tumor was defined as the depth. The distance between the anterior and posterior surface of the tumor was defined as the thickness. The chest wall was defined as the surface of the major pectoral muscle or anterior serratus muscle. The default setting of the maximal depth in our US system was 36 mm, and we were not able to measure the skin-to-chest wall distance in two normal breasts and four tumor-containing breasts. They were excluded from the analysis using the correlation coefficient between optical parameters and the skin-to-chest wall distance. The optical parameters of normal breast tissue were measured in the contralateral breast at the corresponding area. Although the number of tumors examined was 53, the number from normal breasts was 46. The number of the measurement points in the normal side was less than the number of tumors in the patients who had multiple lesions. Net tHb () was defined as the difference between tumor tHb and tHb in normal breast tissue (Fig. 1). The reference curve of the tHb concentration in normal breast tissue as a function of the skin-to-chest wall distance for pre- and postmenopausal patients was derived from the previous study.3 2.5.Statistical AnalysisStatistical examinations were performed using Microsoft Excel 2013 (Microsoft Corporation, Redmond, Washington) and StatFlex version 6.0 (Artech Co., Ltd., Osaka, Japan). The Pearson’s correlation coefficient was calculated to compare the relationship between tHb and tumor thickness, and tumor thickness, tHb and tumor depth, and tumor depth, tumor depth and skin-to-chest wall distance, and the skin-to-chest wall distance, and body mass index (BMI), and and the skin-to-chest wall distance. Linear regression analyses were carried out for each pairing. The differences in and between tumor and normal breast tissues were determined using nonparametric Mann–Whitney U tests. Differences with were considered significant. 3.Results3.1.Total Hemoglobin ConcentrationtHb in normal breast tissue was plotted near the reference curve in both pre- and postmenopausal patients. tHb in breast cancer was plotted above the curve in both pre- and postmenopausal patients [Figs. 2(a) and 2(b)]. Although no correlation was found between tHb and tumor thickness for all the tumors, a positive correlation was found for tumors with a skin-to-chest wall distance larger than 21 mm [Figs. 3(a) and 3(b)]. There was also a positive correlation between and tumor thickness [Fig. 3(c)]. There was a negative correlation between tHb and tumor depth and between and tumor depth [Figs. 4(a) and 4(b)]. The correlation coefficient for tHb was stronger than for . The tumor depth was small in tumors with a small skin-to-chest wall distance [Fig. 4(c)]. 3.2.Tissue Oxygen Saturationin normal breast tissue decreased when the skin-to-chest wall distance decreased [Fig. 5(a)]. The mean in normal breast tissue was (). To minimize the effects of the chest wall, in breast with a skin-to-chest wall distance larger than 21 mm was analyzed. The tumor was lower than normal breast tissue , although the difference was not significant [Fig. 5(b)]. 3.3.Reduced Scattering CoefficientWe reported results on at a wavelength of 795 nm (). In normal breast tissue, a negative correlation was found between and BMI [Fig. 6(a)]. A negative correlation was also found between and age (data not shown). There was a negative correlation between and the skin-to-chest wall distance [Fig. 6(b)]. The in tumors was higher than that in normal breast tissue when the skin-to-chest wall distance was larger than 21 mm [Fig. 6(c)]. 4.DiscussionThe tHb was higher in patients with thick tumors when the skin-to-chest wall distance was larger than 21 mm. As the length of the light path through tumors was long in thick tumors, the tHb measurement was likely to be high. In a previous study, we proposed a subtraction method to assess the hemoglobin concentration, in which the skin-to-chest wall distance was taken into consideration.3 There was a positive correlation between the and tumor thickness for all tumors, including patients with a small skin-to-chest wall distance, suggesting that is a good indicator of tHb for tumors irrespective of the skin-to-chest wall distance. In measurements with a reflection-type probe, the detection sensitivity of the optical measurement had a limit in the depth direction.10 When the tumor was located deep in the breast, tHb measurements were low because of low sensitivity. tHb demonstrated a stronger correlation with tumor depth than . In tumors where the skin-to-chest wall distance was small, the tumor was located near the skin [Fig. 4(c)]. In such situations, tHb measurements may be artificially high, which caused a stronger correlation of tHb with tumor depth. The usefulness of is under investigation in clinical settings. We assessed the therapeutic response to neoadjuvant chemotherapy for breast cancer by spectroscopy and found that reflected therapeutic response more precisely than tHb. tended to be lower in breast cancer than in normal breast tissue when the skin-to-chest wall distance was larger than 21 mm, although the difference was not significant. There has been controversy over in breast cancer. Chance et al.11 reported that in cancer was lower, whereas Grosenick et al.12 and Choe et al.13 reported that in cancer was not lower than that in normal breast tissue. in breast tissue decreased when the skin-to-chest wall distance was small [Fig. 5(a)]. in the antebrachial muscle measured by TRS was reported as ().14 in normal breast tissue measured in this study was (), and can be affected by chest wall muscles. The in normal breast tissue was low in patients with high BMI and in older patients, which is in accordance with the results of previous studies.15,16 Adipose tissue has a lower than glandular tissue.17 A low may reflect high amounts of fat in older patients and in patients with a high BMI. The in normal breast tissue increased when the skin-to-chest wall distance decreased, and the in muscles is reported to be widely distributed.18 The in muscles can be higher than in mammary glands and the measurement of in breast tissue may also be influenced by chest wall muscles. It was reported that the was high in tumors compared with that in normal breast tissue.12,13,19 In this study, the was higher in tumors than in normal breast tissue when the skin-to-chest wall distance was larger than 21 mm. In conclusion, tumor thickness and depth, in addition to chest wall muscles, influenced measurement of tHb by TRS in breast cancer. Our proposed indicator, , reflected the influence of tumor thickness and depth accurately, suggesting it as a good indicator of tHb irrespective of the skin-to-chest wall distance. The measurement of and was also affected by the chest wall. The effects of the chest wall on the measurement of optical properties by TRS should be considered. AcknowledgmentsThis study was partly supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Nos. JP15K19781, JP26282144, and JP17H03591. ReferencesC. Xu et al.,
“Ultrasound-guided diffuse optical tomography for predicting and monitoring neoadjuvant chemotherapy of breast cancers: recent progress,”
Ultrason. Imaging, 38
(1), 5
–18
(2016). https://doi.org/10.1177/0161734615580280 ULIMD4 0161-7346 Google Scholar
S. Ueda et al.,
“Near-infrared diffuse optical imaging for early prediction of breast cancer response to neoadjuvant chemotherapy: a comparative study using 18F-FDG PET/CT,”
J. Nucl. Med., 57
(8), 1189
–1195
(2016). https://doi.org/10.2967/jnumed.115.167320 JNMEAQ 0161-5505 Google Scholar
N. Yoshizawa et al.,
“Effect of the chest wall on the measurement of hemoglobin concentrations by near-infrared time-resolved spectroscopy in normal breast and cancer,”
Breast Cancer, 23
(6), 844
–850
(2016). https://doi.org/10.1007/s12282-015-0650-7 BCATDJ 0161-0112 Google Scholar
S. Ueda et al.,
“Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients,”
PLoS One, 9
(6), e98715
(2014). https://doi.org/10.1371/journal.pone.0098715 POLNCL 1932-6203 Google Scholar
S. Ueda et al.,
“Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,”
Cancer Res., 72
(17), 4318
–4328
(2012). https://doi.org/10.1158/0008-5472.CAN-12-0056 CNREA8 0008-5472 Google Scholar
D. Grosenick et al.,
“Review of optical breast imaging and spectroscopy,”
J. Biomed. Opt., 21
(9), 091311
(2016). https://doi.org/10.1117/1.JBO.21.9.091311 JBOPFO 1083-3668 Google Scholar
M. S. Patterson et al.,
“Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties,”
Appl. Opt., 28
(12), 2331
–2336
(1989). https://doi.org/10.1364/AO.28.002331 APOPAI 0003-6935 Google Scholar
D. V. O'Connor and D. Phillips, Time-Correlated Single Photon Counting, 158
–210 Academic Press, London
(1984). Google Scholar
A. Cerussi et al.,
“In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,”
J. Biomed. Opt., 11
(4), 044005
(2006). https://doi.org/10.1117/1.2337546 JBOPFO 1083-3668 Google Scholar
S. Koga et al.,
“Validation of a high-power, time-resolved, near-infrared spectroscopy system for measurement of superficial and deep muscle deoxygenation during exercise,”
J. Appl. Physiol., 118
(11), 1435
–1442
(2015). https://doi.org/10.1152/japplphysiol.01003.2014 Google Scholar
B. Chance et al.,
“Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study,”
Acad. Radiol., 12
(8), 925
–933
(2005). https://doi.org/10.1016/j.acra.2005.04.016 Google Scholar
D. Grosenick et al.,
“Time-domain scanning optical mammography: II. Optical properties and tissue parameters of 87 carcinomas,”
Phys. Med. Biol., 50
(11), 2451
–2468
(2005). https://doi.org/10.1088/0031-9155/50/11/002 PHMBA7 0031-9155 Google Scholar
R. Choe et al.,
“Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography,”
J. Biomed. Opt., 14
(2), 024020
(2009). https://doi.org/10.1117/1.3103325 JBOPFO 1083-3668 Google Scholar
E. Ohmae et al.,
“Sensitivity correction for the influence of the fat layer on muscle oxygenation and estimation of fat thickness by time-resolved spectroscopy,”
J. Biomed. Opt., 19
(6), 067005
(2014). https://doi.org/10.1117/1.JBO.19.6.067005 JBOPFO 1083-3668 Google Scholar
K. Suzuki et al.,
“Quantitative measurement of optical parameters in normal breasts using time-resolved spectroscopy: in vivo results of 30 Japanese women,”
J. Biomed. Opt., 1
(3), 330
–334
(1996). https://doi.org/10.1117/12.239902 JBOPFO 1083-3668 Google Scholar
W. Mo et al.,
“Quantitative characterization of optical and physiological parameters in normal breasts using time-resolved spectroscopy: in vivo results of 19 Singapore women,”
J. Biomed. Opt., 14
(6), 064004
(2009). https://doi.org/10.1117/1.3257251 JBOPFO 1083-3668 Google Scholar
V. G. Peters et al.,
“Optical properties of normal and diseased human breast tissues in the visible and near infrared,”
Phys. Med. Biol., 35
(9), 1317
–1334
(1990). https://doi.org/10.1088/0031-9155/35/9/010 PHMBA7 0031-9155 Google Scholar
S. L. Jacques,
“Optical properties of biological tissues: a review,”
Phys. Med. Biol., 58
(11), R37
–R61
(2013). https://doi.org/10.1088/0031-9155/58/11/R37 PHMBA7 0031-9155 Google Scholar
Q. Fang et al.,
“Combined optical and x-ray tomosynthesis breast imaging,”
Radiology, 258
(1), 89
–97
(2011). https://doi.org/10.1148/radiol.10082176 RADLAX 0033-8419 Google Scholar
Biography |